472 related articles for article (PubMed ID: 26248379)
1. In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum.
Winzer P; Müller J; Aguado-Martínez A; Rahman M; Balmer V; Manser V; Ortega-Mora LM; Ojo KK; Fan E; Maly DJ; Van Voorhis WC; Hemphill A
Antimicrob Agents Chemother; 2015 Oct; 59(10):6361-74. PubMed ID: 26248379
[TBL] [Abstract][Full Text] [Related]
2. Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites.
Müller J; Aguado-Martínez A; Balmer V; Maly DJ; Fan E; Ortega-Mora LM; Ojo KK; Van Voorhis WC; Hemphill A
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137808
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts.
Imhof D; Anghel N; Winzer P; Balmer V; Ramseier J; Hänggeli K; Choi R; Hulverson MA; Whitman GR; Arnold SLM; Ojo KK; Van Voorhis WC; Doggett JS; Ortega-Mora LM; Hemphill A
Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():90-101. PubMed ID: 34030110
[TBL] [Abstract][Full Text] [Related]
4. Transgenic Neospora caninum strains constitutively expressing the bradyzoite NcSAG4 protein proved to be safe and conferred significant levels of protection against vertical transmission when used as live vaccines in mice.
Marugán-Hernández V; Ortega-Mora LM; Aguado-Martínez A; Jiménez-Ruíz E; Alvarez-García G
Vaccine; 2011 Oct; 29(44):7867-74. PubMed ID: 21816191
[TBL] [Abstract][Full Text] [Related]
5. Gene cloning and characterization of the protein encoded by the Neospora caninum bradyzoite-specific antigen gene BAG1.
Kobayashi T; Narabu S; Yanai Y; Hatano Y; Ito A; Imai S; Ike K
J Parasitol; 2013 Jun; 99(3):453-8. PubMed ID: 23245337
[TBL] [Abstract][Full Text] [Related]
6. MIC3, a novel cross-protective antigen expressed in Toxoplasma gondii and Neospora caninum.
Yang D; Liu J; Hao P; Wang J; Lei T; Shan D; Liu Q
Parasitol Res; 2015 Oct; 114(10):3791-9. PubMed ID: 26141436
[TBL] [Abstract][Full Text] [Related]
7. Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy.
Sánchez-Sánchez R; Ferre I; Re M; Ramos JJ; Regidor-Cerrillo J; Pizarro Díaz M; González-Huecas M; Tabanera E; Benavides J; Hemphill A; Hulverson MA; Barrett LK; Choi R; Whitman GR; Ojo KK; Van Voorhis WC; Ortega-Mora LM
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061151
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites.
Sánchez-Sánchez R; Ferre I; Re M; Vázquez P; Ferrer LM; Blanco-Murcia J; Regidor-Cerrillo J; Pizarro Díaz M; González-Huecas M; Tabanera E; García-Lunar P; Benavides J; Castaño P; Hemphill A; Hulverson MA; Whitman GR; Rivas KL; Choi R; Ojo KK; Barrett LK; Van Voorhis WC; Ortega-Mora LM
Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):112-124. PubMed ID: 29501973
[TBL] [Abstract][Full Text] [Related]
9. Stage-specific expression of Nc SAG4 as a marker of chronic Neospora caninum infection in a mouse model.
Aguado-Martínez A; Ortega-Mora LM; Alvarez-García G; Rodríguez-Marco S; Risco-Castillo V; Marugán-Hernández V; Fernández-García A
Parasitology; 2009 Jun; 136(7):757-64. PubMed ID: 19402941
[TBL] [Abstract][Full Text] [Related]
10. Genetic manipulation of Neospora caninum to express the bradyzoite-specific protein NcSAG4 in tachyzoites.
Marugán-Hernández V; Ortega-Mora LM; Aguado-Martínez A; Alvarez-García G
Parasitology; 2011 Apr; 138(4):472-80. PubMed ID: 21232176
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome and vertical transmission variability among canine Neospora caninum isolates in a pregnant mouse model of infection.
Dellarupe A; Regidor-Cerrillo J; Jiménez-Ruiz E; Schares G; Unzaga JM; Venturini MC; Ortega-Mora LM
Parasitology; 2014 Mar; 141(3):356-66. PubMed ID: 24148606
[TBL] [Abstract][Full Text] [Related]
12. Endochin-like quinolones (ELQs) and bumped kinase inhibitors (BKIs): Synergistic and additive effects of combined treatments against Neospora caninum infection in vitro and in vivo.
Anghel N; Imhof D; Winzer P; Balmer V; Ramseier J; Haenggeli K; Choi R; Hulverson MA; Whitman GR; Arnold SLM; Ojo KK; Van Voorhis WC; Doggett JS; Ortega-Mora LM; Hemphill A
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():92-106. PubMed ID: 34482255
[TBL] [Abstract][Full Text] [Related]
13. Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy.
Ojo KK; Reid MC; Kallur Siddaramaiah L; Müller J; Winzer P; Zhang Z; Keyloun KR; Vidadala RS; Merritt EA; Hol WG; Maly DJ; Fan E; Van Voorhis WC; Hemphill A
PLoS One; 2014; 9(3):e92929. PubMed ID: 24681759
[TBL] [Abstract][Full Text] [Related]
14. The in vitro development of Neospora caninum bradyzoites.
Weiss LM; Ma YF; Halonen S; McAllister MM; Zhang YW
Int J Parasitol; 1999 Oct; 29(10):1713-23. PubMed ID: 10608459
[TBL] [Abstract][Full Text] [Related]
15. Neospora caninum tachyzoite immunome study reveals differences among three biologically different isolates.
Regidor-Cerrillo J; García-Lunar P; Pastor-Fernández I; Álvarez-García G; Collantes-Fernández E; Gómez-Bautista M; Ortega-Mora LM
Vet Parasitol; 2015 Sep; 212(3-4):92-9. PubMed ID: 26324244
[TBL] [Abstract][Full Text] [Related]
16. Immunization of mice with plasmid DNA coding for NcGRA7 or NcsHSP33 confers partial protection against vertical transmission of Neospora caninum.
Liddell S; Parker C; Vinyard B; Jenkins M; Dubey JP
J Parasitol; 2003 Jun; 89(3):496-500. PubMed ID: 12880248
[TBL] [Abstract][Full Text] [Related]
17. Oocysts of Neospora caninum, Hammondia heydorni, Toxoplasma gondii and Hammondia hammondi in faeces collected from dogs in Germany.
Schares G; Pantchev N; Barutzki D; Heydorn AO; Bauer C; Conraths FJ
Int J Parasitol; 2005 Dec; 35(14):1525-37. PubMed ID: 16197949
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of mice with Neospora caninum: response to oral challenge with Toxoplasma gondii oocysts.
Lindsay DS; Lenz SD; Dykstra CC; Blagburn BL; Dubey JP
J Parasitol; 1998 Apr; 84(2):311-5. PubMed ID: 9576504
[TBL] [Abstract][Full Text] [Related]
19. Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice.
Zhang G; Huang X; Boldbaatar D; Battur B; Battsetseg B; Zhang H; Yu L; Li Y; Luo Y; Cao S; Goo YK; Yamagishi J; Zhou J; Zhang S; Suzuki H; Igarashi I; Mikami T; Nishikawa Y; Xuan X
Vaccine; 2010 Oct; 28(45):7243-7. PubMed ID: 20832493
[TBL] [Abstract][Full Text] [Related]
20. In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoites.
Jiménez-Meléndez A; Ojo KK; Wallace AM; Smith TR; Hemphill A; Balmer V; Regidor-Cerrillo J; Ortega-Mora LM; Hehl AB; Fan E; Maly DJ; Van Voorhis WC; Álvarez-García G
Int J Parasitol; 2017 Oct; 47(12):811-821. PubMed ID: 28899692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
